Velabs Therapeutics
- Anna Pryszlak
Anna Pryszlak
Director Antibody Screening at Velabs Therapeutics
Anna Pryszlak is currently the Director of Antibody Screening at VERAXA Biotech GmbH. Prior to this role, Anna held positions as the Head of Screening and Principal Scientist for Technology Development at Velabs Therapeutics GmbH. Anna has a background in molecular therapy of virus-associated cancers and has experience working as a postdoctoral researcher at EMBL. Anna holds a Doctor of Philosophy degree in Natural Sciences from Heidelberg University.
Org chart
Timeline
Director Antibody Screening
April 1, 2024 - present
Head Of Screening
February, 2021
Related people
Sandro Arbulu
Director | Lead Portfolio Manager at DWS Group
Dan Fish
Executive Director Supply Chain at Amgen
Taylor Anderson
Head Of Sustainable Portfolio Solutions, Americas at DWS Group
Tom Wootton
Global Head Treasury & Liquidity Risk Management at Credit Suisse
Marco Benthem
Executive Director Regional Supply Chain EMEA at Amgen
EVERY ORG CHART
Access the worlds's biggest network of public org charts
Learn more